Ark Therapeutics Group PLC Holding(s) in Company (2932E)
May 08 2013 - 12:47PM
UK Regulatory
TIDMAKT
RNS Number : 2932E
Ark Therapeutics Group PLC
08 May 2013
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or the underlying Ark Therapeutics plc
issuer
of existing shares to which voting rights
are
attached: (ii)
-------------------------------------------------- ----------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
--------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
----------------------------------------------------------------------------- -------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
----------------------------------------------------------------------------- -------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
----------------------------------------------------------------------------- -------
An event changing the breakdown of voting rights
----------------------------------------------------------------------------- -------
Other (please
specify):
------------------- -------------------------------------------------------- -------
3. Full name of person(s) subject D.A.Phillips / K.F Phillips
to the
notification obligation: (iii)
-------------------------------------------- ----------------------------------------
4. Full name of shareholder(s) Aquaglow ltd
(if different from 3.):(iv) D.A.A.Phillips
K.F.Phillips
-------------------------------------------- ----------------------------------------
5. Date of the transaction and date 29/04/2013
on
which the threshold is crossed
or
reached: (v)
-------------------------------------------- ----------------------------------------
6. Date on which issuer notified: 08/05//2013
-------------------------------------------- ----------------------------------------
7. Threshold(s) that is/are crossed From 8% to 9%
or
reached: (vi, vii)
-------------------------------------------- ----------------------------------------
8. Notified details:
-------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
-------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if
possible
using
the ISIN
CODE
----------- ------------------------------------ ----------------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights (x)
Shares Voting
Rights
----------- ---------------- ------------------ ------------- ----------------------- ------------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
----------- ----- ------- ------ ------ ------------- ------------ --------- --------------- -------------
Ordinary
1p 17,360,000 18,860,000 9.01%
----------- ---------------- ------------------ ------------- ------------ --------- --------------- -------------
B: Qualifying Financial Instruments
-------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion Period rights that may rights
(xiv) be
acquired if the
instrument is
exercised/ converted.
-------------------- --------------- ------------------------------- ---------------------------- -------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments (xv, xvi)
-------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting rights
financial price date (xvii) Conversion rights instrument (xix, xx)
instrument period refers to
(xviii)
------------- -------------- -------------- ----------------- ---------------------------- -------------------------
Nominal Delta
------------- -------------- -------------- ----------------- ---------------------------- ------------- ----------
Total (A+B+C)
-------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
-------------------------------------------------------------- ---------------------------------------------------------
18,860,000 9.01%
-------------------------------------------------------------- ---------------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable: (xxi)
--------------------------------------------------------------------------------
Proxy Voting:
--------------------------------------------------------------------------------
10. Name of the proxy holder: Investec/Charles Stanley
--------------------------------------------------- ---------------------------
11. Number of voting rights proxy holder will
cease
to hold:
--------------------------------------------------- ---------------------------
12. Date on which proxy holder will cease to
hold
voting rights:
--------------------------------------------------- ---------------------------
13. Additional information:
---------------------------------------- --------------------------------------
14. Contact name: D.Phillips
---------------------------------------- --------------------------------------
15. Contact telephone number: 07775141617
---------------------------------------- --------------------------------------
Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in share
A: Identity of the persons or legal entity subject to the notification
obligation
-----------------------------------------------------------------------
Full name
(including legal form of legal entities)
-----------------------------------------------------------------------
Contact address
(registered office for legal entities)
-----------------------------------------------------------------------
Phone number & email
-----------------------------------------------------------------------
Other useful information
(at least legal representative for
legal persons)
-----------------------------------------------------------------------
B: Identity of the notifier, if applicable
-----------------------------------------------------------------------
Full name
-----------------------------------------------------------------------
Contact address
-----------------------------------------------------------------------
Phone number & email
-----------------------------------------------------------------------
Other useful information
(e.g. functional relationship with
the person or legal entity subject
to the notification obligation)
-----------------------------------------------------------------------
C: Additional information
-----------------------------------------------------------------------
For notes on how to complete form TR-1 please see the FSA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUWONROWAVRAR
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jul 2023 to Jul 2024